AI assistant
Biohit Oyj — Director's Dealing 2017
Feb 23, 2017
3304_dirs_2017-02-23_844467cb-fc8b-4c05-a125-50bbfc44a5eb.html
Director's Dealing
Open in viewerOpens in your device viewer
Disclosure 349433
Biohit Oyj - Managers' transactions
Biohit Oyj - Managers' Transactions
Biohit Oyj - Managers' Transactions, February 23, 2017 at 3:05 pm local time (EET) ____________________________________________ Person subject to the notification requirement Name: Patrakka, Ilari Position: Other senior manager Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29 Notification type: INITIAL NOTIFICATION Reference number: 74370089ATTSNBXJVT29_20170223120028_5 ____________________________________________ Transaction date: 2017-02-20 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT ISIN: FI4000219324 Nature of the transaction: SUBSCRIPTION (X) Linked to stock option programme Transaction Details (1): Volume: 1450 Unit price: 2,27660 EUR Aggregated transactions (1): Volume: 1450 Volume weighted average price: 2.27660 EUR Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 [email protected] www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com